Impact of Nanoliposomes on Hepatitis Virus Pathways: A narrative Review
Journal of Medical and Oral Biosciences · 2025
DOI: 10.58564/jmob.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical and Oral Biosciences, 2025. Verfasst von Bushra Shihab Hamad Bushra Shihab Hamad und 2 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Hepatitis viruses keep up to remain a significant worldwide health threat owing to their chronic nature, severe hepatic consequences, accompanied withthelimited effectiveness of standard treatments. Nanoliposomes, which are lipid-based nanocarriers, have a lot of potential for improving the administration of antiviral drugs by making them more bioavailable, targeting the liver, and changing how the immune system works. This study intends to focus on the latest developments in the design, physicochemical properties, and processes of nanoliposomes that stop the hepatitis virus from spreading, with an emphasis on the hepatitis B and C viruses. Recent investigations demonstrate their capacity to improve antiviral drug stability, promote hepatic macrophage targeting, and impede viral multiplication,while diminishing systemic toxicity. Additionally, the research article addresses biocompatibility issues, the constraints of existing
Zitieren
APA
Hamad, B. S. H. B. S., Shukr, S. M., & Abbood, A. S. (2025). Impact of Nanoliposomes on Hepatitis Virus Pathways: A narrative Review. Journal of Medical and Oral Biosciences. https://doi.org/10.58564/jmob.103
Vancouver
Hamad BSHBS, Shukr SM, Abbood AS. Impact of Nanoliposomes on Hepatitis Virus Pathways: A narrative Review. Journal of Medical and Oral Biosciences. 2025. doi:10.58564/jmob.103
BibTeX
@article{Hamad2025,
author = {Hamad, Bushra Shihab Hamad Bushra Shihab and Shukr, Shahlaa Mahdi and Abbood, Alaa Saadi},
title = {Impact of Nanoliposomes on Hepatitis Virus Pathways: A narrative Review},
journal = {Journal of Medical and Oral Biosciences},
year = {2025},
doi = {10.58564/jmob.103}
}
EUVIMED